DSK Co (109740) Fair Value & Analysis
Technology · KR · Market cap 164B KRW
Fair value as of: Jun 25, 2026
Analysis
DSK Co (109740) currently trades at 5,530 KRW, while our model-based Fair Value estimate is 553.11 KRW — implying the stock looks roughly 90.0% overvalued today. We read business quality at 85/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
DSK Co., Ltd., a process equipment company, develops and supplies systems and parts for the display factory automation industry in South Korea and internationally. It offers PCB/FOB bonders, TAB/COF bonders, FPC/FOG bonders, inspection/silicon dispensers, Ag dotting systems, loaders/unloaders, laser marking systems, laser marking and 2D labelers, atomic layer deposition systems for solar cell, and UV LED curing systems; auto probe stations and prober units; linear and robot systems, and DD motors; and LED negative ion air purifiers. The company also manufactures and sells medicines, antidotes, and biobetters using botulinum toxin; and offers diode pumping solid state laser and pumped laser systems. Its products are primarily used in flat panel displays, solar cells, secondary batteries, and other products. The company was formerly known as Dong Bang Fanics Corporation and changed its name to DSK Co., Ltd. in 2008. DSK Co., Ltd. was founded in 1995 and is headquartered in Ansan, Sout…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is DSK Co (109740) undervalued?
What is the fair value of 109740?
What is the quality score of 109740?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.